Chandler W L, Veith R C, Fellingham G W, Levy W C, Schwartz R S, Cerqueira M D, Kahn S E, Larson V G, Cain K C, Beard J C
Department of Laboratory Medicine, University of Washington, Seattle 98195.
J Am Coll Cardiol. 1992 Jun;19(7):1412-20. doi: 10.1016/0735-1097(92)90596-f.
To determine whether exercise-induced increases in tissue plasminogen activator (t-PA) were related to plasma epinephrine concentration during exercise, 14 healthy men (aged 24 to 62 years) were studied during epinephrine infusions (10, 25 and 50 ng/kg per min) and graded supine bicycle exercise, beginning at 33 W and increasing in 33-W increments until exhaustion. Plasma epinephrine, active and total t-PA, active plasminogen activator inhibitor type 1 (PAI-1) and t-PA/PAI-1 complex concentrations were measured at each exercise and infusion level. During epinephrine infusion, active and total t-PA levels increased linearly with the plasma epinephrine concentration (respective slopes [+/- SEM] of 0.062 +/- 0.003 and 0.076 +/- 0.003 pmol/ng epinephrine). During exercise, t-PA levels did not increase until plasma epinephrine levels increased, after which both active and total t-PA levels again increased linearly with the plasma epinephrine concentration, but at twice the rate observed with epinephrine infusion (0.131 +/- 0.005 and 0.147 +/- 0.005 pmol/ng, respectively). The t-PA level in blood was directly proportional to the plasma epinephrine concentration during both exercise and epinephrine infusion, suggesting that epinephrine release during exercise stimulates t-PA secretion. In these healthy subjects, active plasminogen activator inhibitor type 1 and t-PA/PAI-1 complex levels were low (41 +/- 11 and 21 +/- 5 pmol/liter, respectively) and did not change significantly during exercise or epinephrine infusion. It is concluded that approximately 50% of the increase in t-PA during exercise is due to stimulated release of t-PA by epinephrine.(ABSTRACT TRUNCATED AT 250 WORDS)
为了确定运动诱导的组织型纤溶酶原激活物(t-PA)增加是否与运动期间血浆肾上腺素浓度相关,对14名健康男性(年龄24至62岁)在肾上腺素输注(每分钟10、25和50 ng/kg)和分级仰卧位自行车运动期间进行了研究,运动从33 W开始,以33 W的增量增加直至疲劳。在每个运动和输注水平测量血浆肾上腺素、活性和总t-PA、活性纤溶酶原激活物抑制剂1型(PAI-1)以及t-PA/PAI-1复合物浓度。在肾上腺素输注期间,活性和总t-PA水平随血浆肾上腺素浓度呈线性增加(分别为0.062±0.003和0.076±0.003 pmol/ng肾上腺素的斜率[±SEM])。在运动期间,t-PA水平直到血浆肾上腺素水平增加才升高,此后活性和总t-PA水平再次随血浆肾上腺素浓度呈线性增加,但速率是肾上腺素输注时观察到的两倍(分别为0.131±0.005和0.147±0.005 pmol/ng)。在运动和肾上腺素输注期间,血液中的t-PA水平均与血浆肾上腺素浓度成正比,表明运动期间肾上腺素释放刺激t-PA分泌。在这些健康受试者中,活性纤溶酶原激活物抑制剂1型和t-PA/PAI-1复合物水平较低(分别为41±11和21±5 pmol/升),在运动或肾上腺素输注期间无显著变化。得出结论,运动期间t-PA增加的约50%是由于肾上腺素刺激t-PA释放所致。(摘要截短为250字)